Morgan Stanley maintains HP at Underweight, raises price target to $21 from $19

Morgan Stanley kept HP Inc. at Underweight but raised its price target to $21 from $19, implying a 28.5% downside from the Nov 13 close of $29.36.

Original reporting
Published Nov 16, 2026, 3:14 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 16, 2026, 3:24 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Morgan Stanley maintains HP at Underweight, raises price target to $21 from $19 — source image
Decision brief

The 30-second read

$HPBearishMed
01

Why it matters

The downgrade in target may lead to short-term selling pressure, but the modest increase from $19 to $21 could attract value-oriented investors.

02

Market read

Analyst price target updates are common catalysts for short-term price moves, especially when the target remains below current levels.

03

What to watch

Potential upside from upcoming product launches or cost reductions not captured in the target.

Relevance 6/10Novelty 6/10Timing: today

Background

Morgan Stanley's research note updates its valuation for HP Inc. after recent market movements.

Company-level read

Ticker impact

$HPBearishHigh confidence
Context

Morgan Stanley raised HP's price target to $21 from $19, indicating a modest upside but still below current price.

Expected impact

likely pressure as the market prices in the lower target relative to current price

Evidence & confidence

Analyst target is below the recent close, signaling limited upside and potential downside risk.

Market effects

Minimal impact on the broader PC hardware sector; only reflects one analyst's view.

Limited to U.S. markets where HP trades.

Low; does not affect global indices.

Counterpoint

Investors may view the target raise as a buying opportunity if they believe the market has overreacted to recent price declines.

Key entities

  • Morgan Stanley

    Equity research firm providing the price target update.

  • HP Inc.

    U.S.-listed PC and printer manufacturer.

Related articles

$HPLow

From cosmetics to drugs to PCs, Walmsley faces fresh outsider test at HP

HP Inc has appointed Emma Walmsley, former CEO of GSK, as its next CEO. Walmsley, known for her transformative leadership, will navigate HP through industry downturns and supply-chain issues. She has experience in diverse sectors, including cosmetics and pharmaceuticals, and has served on Microsoft's board since 2019. Analysts highlight her potential to drive HP's AI initiatives, though rising memory-chip costs pose an immediate challenge.

$HPMed

HP Appoints Former GSK Chief Emma Walmsley As CEO

HP Inc. has appointed Emma Walmsley, former CEO of GSK, as its new CEO, effective January 4, 2027. She succeeds interim CEO Bruce Broussard, who will become chairman. Walmsley brings experience in leading large organizations and aims to leverage AI for growth, according to HP.

$HPMed

Helmerich & Payne: Q4 FY2026 previews strong direct margins, activity near high end of guidance

Helmerich & Payne (HP) anticipates strong Q4 FY2026 results, with direct margins near high-end guidance for North America, International, and Offshore Solutions. International Solutions direct margin is expected around $45 million. Activity levels vary by region, with North America near the high end and others near midpoints. The company reaffirmed its fiscal 2027 outlook and debt reduction target of 1x net debt to adjusted EBITDA by year-end 2027, while maintaining its base dividend.

$HPMed

Helmerich & Payne, Inc. (HP): H&P PROVIDES FOURTH QUARTER FINANCIAL & OPERATIONAL UPDATE

Helmerich & Payne, Inc. (HP) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 NEWS RELEASE H&P PROVIDES FOURTH QUARTER FINANCIAL & OPERATIONAL UPDATE TULSA, Okla. – October 7, 2026 – Helmerich & Payne, Inc. (NYSE: HP) currently expects to report strong operational and segment financial results for the quarter, with direct margins (1) for its N

$PUMPMed

Q2 Earnings Roundup: ProPetro (NYSE:PUMP) And The Rest Of The Oilfield Services Segment

ProPetro (PUMP) is up 10% post-earnings at $11.73. Select Water Solutions (WTTR) reported $395.8M revenue, up 8.7% YoY, beating estimates, and its stock rose 8.7% to $20.11. Borr Drilling (BORR) saw revenue decline 13.2% YoY, missing estimates, but its stock increased 14.6% to $4.88. Bristow Group (VTOL) reported $411.8M revenue, up 9.4% YoY, beating expectations, but its stock fell 5.2% to $45.24. Helmerich & Payne (HP) reported flat revenue but beat estimates, with its stock up 40.9% to $46.90